December 27, 2019 7:38pm

December and Q4 are almost over with 9 positive, 1 holiday and 10 negative closes

Also the week’s numbers in review

Be safe if traveling and open to new motivation for portfolio return from RMi

 


 

I think Aristotle may have been the first to crystallize the fallacies (in writing at least) of many situations we are trying to deal with. Ad Verecundiam (Appeal to Authority) is certainly one fallacy, Ad Metum (Appeal to Fear) is the answer to the argument!

 

The Dow closed up +23.87 points (+0.308%), the S&P closed up +0.11 points (+0.00%) and the NASDAQ closed down -15.77 points (-0.17%)

 

The iShares NASDAQ Biotechnology (IBB) and the SPDR S&P ETF (XBI) indicators:

  • Friday the IBB closed down -1.02% while and XBI closed down -1.37%
  • Thursday the IBB closed down -0.92% while and XBI closed down -0.85%
  • Wednesday markets were closed;
  • Tuesday the IBB closed up +0.58% while and XBI closed up +0.75%
  • Monday the IBB closed up +0.87% while and XBI closed up +1.01%

 

The advance/decline line scenario of 45 covered companies:

  • Friday the close was negative with an A/D line of 10/26, 0 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);
  • Thursday the close was negative with an A/D line of 16/20, 2 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);
  • Wednesday was Christmas Day;
  • Tuesday the close was positive with an A/D line of 27/10, 1 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);
  • Monday the close was positive with an A/D line of 33/5, 1 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);

 

Henry’omics:

Indexes notched fresh records on Friday as year-end optimism continued to drive the rally.

Not for our universe of cell and gene therapy as share pricing takes its toll.

The Dow had a record close, the S&P 500 finished also with a new closing high. However, the NASDAQ slipped snapping an 11-day winning streak.

Stocks notched fresh records on Friday as year-end optimism continued to drive the rally.

The S&P 500, up already more than 29% in 2019, is inches away from reaching historic proportions. The benchmark will post its best year since 1997 with an annual gain of more than 29.6%. The NASDAQ topped the 9,000 mark for the first time Thursday.

Trading volumes were light throughout the end of the holiday-shortened week.

 

Reiterating, “Selling the highs has an advantage for bargains will be available toward the end of January post the JPMorgan healthcare conference in early January.”

 

Decliners:

  • Global Blood Therapeutics (GBT -$2.71 after Thursday’s +$0.59, Tuesday’s +$1.04, Monday’s +$3.36 and last Friday’s +$1.060;
  • bluebird bio (BLUE -$2.14 after Thursday’s -$4.68, Tuesday’s +$5.44 and Monday’s -$2.54);
  • uniQure NV (QURE -$2.12 after Thursday’s +$1.01, Tuesday’s +$1.78, Monday’s +$2.47 and last  Friday’s -$0.63);
  • Ultragenyx (RARE -$1.84);
  • Editas Medicine (EDIT -$1.590;

Incliners:

  • AxoGen (AXGN +$0.37);
  • ThermoGenesis (KOOL +$0.35 after Thursday’s +$0.35);
  • Biostage (BSTG +$0.145);
  • Caladrius Biosciences (CLBS +$0.14);
  • ReNeuron (RENE.L +$4.00 after Thursday’s -$1.00 after Tuesday’s -$1.00 after Monday’s +$3.50);

 

The percentage (%) indicators:

  • Friday’s range of the 10 upside was +0.06% (BOLD) to +7.31% (KOOL) while the 20 downside ranged from -0.20% (ALNY) to -8.27% (ADVM); 
  • Thursday’s range of the 16 upside was +0.05% (AXGN) to +12.28% (BLCM) while the 20 downside ranged from -0.06% (BMRN) to -7.90% (XON); 
  • Wednesday markets were closed; 
  • Tuesday closed POSITIVE with 10 decliners, 27 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);
  • Monday’s range of the 32 upside was +0.14% (MDXG) to +11.22% (ADRO) while the 5 downside ranged from -0.08% BLUE) to -0.73% (SAGE); 

 

Upside volume stats:  to compare

  • Friday: 6 out of the 16 upside had higher than the 3 month average volume;
  • Thursday: 8 out of the 16 upside had higher than the 3 month average volume;
  • Wednesday: markets closed;
  • Tuesday: 5 out of the 27 upside had higher than the 3 month average volume;
  • Monday: 9 out of the 35 upside had higher than the 3 month average volume;

Downside volume stats:

  • Friday: 7 out of the 20 downside had higher than the 3 month average volume;
  • Thursday: 3 out of the 20 downside had higher than the 3 month average volume;
  • Wednesday: markets closed;
  • Tuesday: 2 out of the 10 downside had higher than the 3 month average volume;
  • Monday: 1 out of the 2 downside had higher than the 3 month average volume;

 

0 flat

 

December’s sessions:

Friday closed NEGATIVE with 20 decliners, 10 advancers, 2 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Thursday closed NEGATIVE with 20 decliners, 16 advancers, 2 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Wednesday markets were closed;

Tuesday closed POSITIVE with 10 decliners, 27 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Monday closed POSITIVE with 2 decliners, 35 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Friday closed NEGATIVE with 19 decliners, 15 advancers, 3 flats, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Thursday closed POSITIVE with 12 decliners, 24 advancers, 2 flats, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Wednesday closed NEGATIVE with 23 decliners, 13 advancers, 3 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Tuesday closed NEGATIVE with 22 decliners, 16 advancers, 1 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Monday closed POSITIVE with 13 decliners, 25 advancers, 1 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Friday closed NEGATIVE with 24 decliners, 16 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed POSITIVE with 14 decliners, 27 advancers, 0 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed NEGATIVE with 13 decliners, 27 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed POSITIVE with 17 decliners, 22 advancers, 2 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGATIVE with 31 decliners, 9 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Friday closed POSITIVE with 9 decliners, 29 advancers, 3 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed NEGATIVE with 31 decliners, 9 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed POSITIVE with 13 decliners, 25 advancers, 4 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed POSITIVE with 12 decliners, 25 advancers, 4 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGATIVE with 26 decliners, 19 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.